RxDoctor Payments Data

Brittany Delaughter

Family · Sikeston, MONPI 1003264920

Payments from drug & device makers

$380in general payments, 2019–2025

Across 21 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Phathom Pharmaceuticals, Inc.$69
  • Sunovion Pharmaceuticals Inc.$48
  • Lilly USA, LLC$44
  • AstraZeneca$37
  • Merz North America, Inc.$37
  • Kowa Pharmaceuticals America, Inc.$31
  • plus $114 from 6 others

What the payments were for

  • Food & beverage$380100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$380 in reported general payments places this provider in the 45th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$3,725
Medicare patients
109
Services billed
148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide42$40,875
MounjaroTirzepatide29$30,372
EliquisApixaban32$24,482
OzempicSemaglutide23$20,545
JardianceEmpagliflozin22$19,614
NuedextaDextromethorphan Hbr/Quinidine12$19,383
JanuviaSitagliptin Phosphate33$16,914
FarxigaDapagliflozin Propanediol17$10,846
VascepaIcosapent Ethyl27$9,321
Combivent RespimatIpratropium/Albuterol Sulfate15$8,064
GemtesaVibegron15$7,729
LinzessLinaclotide11$5,830
Pregabalin52$4,193
Dexlansoprazole DrDexlansoprazole11$3,979
Levemir FlexpenInsulin Detemir18$2,901

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$44$71,24771 claims
PfizerEliquis$14$24,48232 claims
AstraZenecaFarxiga$37$10,84617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,812 family providers in Missouri.

Other family in Sikeston

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →